Page last updated: 2024-10-29

indomethacin and Leprosy, Cutaneous

indomethacin has been researched along with Leprosy, Cutaneous in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misra, N1
Selvakumar, M1
Singh, S1
Bharadwaj, M1
Ramesh, V1
Misra, RS1
Nath, I1

Other Studies

1 other study available for indomethacin and Leprosy, Cutaneous

ArticleYear
Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy.
    Immunology letters, 1995, Volume: 48, Issue:2

    Topics: Antibodies; Cells, Cultured; Dinoprostone; Humans; Immune Tolerance; Indomethacin; Interleukin-10; L

1995